BRIEF-Zogenix drops in premarket after FDA panel recommendation

NEW YORK Mon Dec 10, 2012 7:41am EST

NEW YORK Dec 10 (Reuters) - Zogenix Inc : * Drops 42 percent to $1.37 in premarket after a U.S. Food and Drug Administration panel of outside experts on Friday voted against recommending the company's Zohydro painkiller for approval